Mammography

Feature #21935 – Additional Columns for ACR Category 0 Follow Up and ACR Category 4/5 Follow Up Mammography Worklist

Summary

This enhancement to Mammography adds new columns to the ACR Category 0 and ACR Category 4/5 follow up worklists to allow users to more effectively identify when a patient needs to be actioned or if special accommodations are needed without having to open each mammography study.

Feature Description

New Breast Study Scheduled Date and Breast Study Schedule Procedure columns have been added to the ACR Category 0 follow up worklist and new Biopsy Scheduled Date and Biopsy Scheduled Procedure columns have been added to the ACR Category 4/5 follow up worklist.

Additionally, existing columns such as the Preferred Language and Alerts have been added to both worklists.

Previously, there was no way to effectively identify when a patient needed to be actioned on either the ACR Category 0 follow up worklist or the ACR Category 4/5 follow up worklist without having to open each mammography study in the patient folder and look through all of the notes.

Additionally, without seeing the patient’s preferred language and patient alerts on either of the follow up worklists, users were unaware whether special accommodations needed to be made to assist the patient.

With this change, users will now experience an enhancement in the workflow by being able to identify needed information such as the next scheduled biopsy and/or next scheduled breast study from the worklist. Users will also have the ability to view preferred language and/or any patient alerts from the worklist that might be pertinent to the patient’s care.

New Columns

The new Breast Study Scheduled Date column will show the schedule date of the next BI-RADS® enabled exam in any of the following exams statuses, (Scheduled, Checking In, Arrived, Started, Exam Done, Dictated, Transcribed, Signed*, and Signed). The date will be displayed when the scheduled date is at least 1 calendar day following the BI-RADS® 0 study and is no more than the number of calendar days into the future from the date of service of the study as configured in the new MaxDaysForB0FU system configuration setting.

The new Breast Study Scheduled Procedure column will show the Procedure Description for the procedure identified in the Breast Study Scheduled Date column.

The new Biopsy Schedule Date column will show the scheduled date of the next biopsy enabled study with a body part equal to the existing system configuration setting, BreastBodyPartCode in any of the following exam statuses (Scheduled, Checking In, Arrived, Started, Exam Done, Dictated, Transcribed, Signed* and Signed) and when the scheduled date is no more than the number of calendar days into the future from the date the BI-RADS® 4/5 report was signed as as configured in the new MaxDaysForB45FU system configuration setting.

The new Biopsy Scheduled Procedure column will show the Procedure Description for the procedure identified in the Biopsy Scheduled Date column.

Configuration Instructions

System Administrators must complete the following actions to enable this feature:

RIS Client

Changes to SystemConfig Lookup Table

·         Configure MaxDaysForB0FU and MaxDaysForB45FU as desired.

The following related settings were added or updated:

Setting

Default

Purpose

MaxDaysForB0FU

Value=Days as String, Default=[30]

Maximum number of calendar days for a BI-RADS Enabled study to be considered for display in ACR Category 0 Follow-up WL columns "Breast Study Scheduled Date" and "Breast Study Scheduled Procedure". The number of days between the date the BI-RADS 0 report was signed and the date of the next study. Added in v4.2022.11.2 #21935

MaxDaysForB45FU

Value=Days as String, Default=[30]

Maximum number of calendar days for a breast biopsy study to be considered for display in ACR Category 4/5 Follow-up WL columns "Biopsy Scheduled Date", "Biopsy Scheduled Procedure" and "Biopsy Pathology Date". The number of days between the date the BI-RADS 4 or 5 report was signed and the date of the next study. Added in v4.2022.11.2 #21935